Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Telehealth Act Introduced In US House Would Eliminate Geographic Originating Site Restrictions

Executive Summary

A bipartisan group of US House members have introduced the Protecting Access to Post-COVID-19 Telehealth Act, a bill to ease Medicare beneficiaries’ telemedicine access.

You may also be interested in...



Market Intel: Why Telehealth, Digital Therapies Will Provide Mental Health Support Beyond COVID-19 Crisis

In this second part of a two-part series focusing on mental health tech, Medtech Insight highlights behavioral digital health companies that have attracted investors’ attention. Part one focused on transcranial magnetic stimulation.

Telehealth: Trump EO Would Extend Payments, While CMS Proposes Permanent Rule

An executive order signed by the US president calls on the Medicare agency to extend telehealth reimbursements beyond the pandemic.

Senate Republicans Pledge To Build Up Stockpiles Of COVID-19 Diagnostics, Supplies, Under HEALS Act

One of eight legislative bills put out by GOP senators under the umbrella of the HEALS Act coronavirus relief package on 27 July would build up stockpiles of diagnostics and medical supplies.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT142450

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel